[go: up one dir, main page]

AU2002334001A1 - Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia - Google Patents

Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia

Info

Publication number
AU2002334001A1
AU2002334001A1 AU2002334001A AU2002334001A AU2002334001A1 AU 2002334001 A1 AU2002334001 A1 AU 2002334001A1 AU 2002334001 A AU2002334001 A AU 2002334001A AU 2002334001 A AU2002334001 A AU 2002334001A AU 2002334001 A1 AU2002334001 A1 AU 2002334001A1
Authority
AU
Australia
Prior art keywords
medicine
preparing
ginkgo biloba
biloba extracts
treating sarcopenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002334001A
Other versions
AU2002334001B2 (en
Inventor
Yves Christen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Ipsen Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0109506A external-priority patent/FR2827518B1/en
Application filed by Ipsen Pharma SAS filed Critical Ipsen Pharma SAS
Publication of AU2002334001A1 publication Critical patent/AU2002334001A1/en
Priority to AU2003273444A priority Critical patent/AU2003273444B2/en
Application granted granted Critical
Publication of AU2002334001B2 publication Critical patent/AU2002334001B2/en
Assigned to IPSEN PHARMA S.A.S reassignment IPSEN PHARMA S.A.S Alteration of Name(s) in Register under S187 Assignors: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002334001A 2001-07-17 2002-07-16 Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia Ceased AU2002334001B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003273444A AU2003273444B2 (en) 2001-07-17 2003-07-15 Use of Ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/09506 2001-07-17
FR0109506A FR2827518B1 (en) 2001-07-17 2001-07-17 USE OF GINKGO BILOBA EXTRACTS FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF SARCOPENIA
PCT/FR2002/002519 WO2003007973A1 (en) 2001-07-17 2002-07-16 Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2003273444A Division AU2003273444B2 (en) 2001-07-17 2003-07-15 Use of Ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass

Publications (2)

Publication Number Publication Date
AU2002334001A1 true AU2002334001A1 (en) 2003-05-22
AU2002334001B2 AU2002334001B2 (en) 2007-07-19

Family

ID=8865590

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002334001A Ceased AU2002334001B2 (en) 2001-07-17 2002-07-16 Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia

Country Status (17)

Country Link
US (2) US7138148B2 (en)
EP (1) EP1411961B1 (en)
JP (1) JP4510445B2 (en)
KR (1) KR100891393B1 (en)
CN (1) CN1272016C (en)
AT (1) ATE304861T1 (en)
AU (1) AU2002334001B2 (en)
CA (1) CA2453254C (en)
DE (1) DE60206280T2 (en)
DK (1) DK1411961T3 (en)
ES (1) ES2250726T3 (en)
FR (1) FR2827518B1 (en)
HU (1) HUP0400928A3 (en)
NZ (1) NZ530367A (en)
PL (1) PL202567B1 (en)
RU (1) RU2298411C2 (en)
WO (1) WO2003007973A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842425B1 (en) * 2002-07-16 2005-04-08 Sod Conseils Rech Applic USE OF GINKGO BILOBA EXTRACTS TO PROMOTE MUSCLE MASS AT DETRIMENT OF FAT MASS
US8058211B2 (en) * 2007-12-12 2011-11-15 Halliburton Energy Services, Inc. Corrosion inhibitor intensifier compositions and associated methods
JP2013519869A (en) 2010-02-10 2013-05-30 ノバルティス アーゲー Methods and compounds for muscle growth
US9029558B2 (en) 2011-08-18 2015-05-12 Semiconductor Energy Laboratory Co., Ltd. Carbazole compound, light-emitting element, light-emitting device, electronic device, and lighting device
KR102051433B1 (en) 2013-08-27 2020-01-08 (주)네오팜 A composition and external application for acceleration of muscle differentiation and improving of muscle mass
KR101771486B1 (en) 2015-06-25 2017-08-25 서울대학교산학협력단 The method for preparing panax ginseng extract with increased contents of selective dammaranes, and a pharmaceutical compositions of the same for prevention or treatment of sarcopenia-related diseases
KR102281263B1 (en) 2019-03-12 2021-07-26 주식회사 비티씨 Enzyme treated catechin product containing increased gallic acid, epicatechin and epigallocatechin content and preparation method thereof
EP3934441A1 (en) 2019-05-31 2022-01-12 Société des Produits Nestlé S.A. Mct-based nutrition blend for providing health benefits in animals
KR102229177B1 (en) 2019-12-27 2021-03-18 부산대학교 산학협력단 Composition for preventing or treating sarcopenia comprising extract of rosemary and soybean
KR20240133112A (en) 2023-02-28 2024-09-04 주식회사 건강중심주의 Composition for preventing, improving or treating muscle sarcopenia-related disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (en) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe MEDICINAL PRODUCTS CONTAINING BILOBALID
US5002965A (en) * 1989-05-09 1991-03-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Use of ginkgolides to prevent reperfusion injury in organ transplantation
AU3582597A (en) * 1996-06-28 1998-01-21 Viva America Marketing, Inc. Nutritional supplement composition and use
FR2763592B1 (en) * 1997-05-20 1999-07-16 Sod Conseils Rech Applic NOVEL GLYCOSYL DERIVATIVES OF GINKGOLIDES, THEIR APPLICATION AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP3293524B2 (en) * 1997-06-17 2002-06-17 有限会社薬研 Ginkgo biloba leaf extract-supported powder composite and method for producing the same
FR2771639B1 (en) * 1997-12-03 2000-05-05 Sod Conseils Rech Applic USE OF GINKGO BILOBA EXTRACTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR FACILITATING THE WITHDRAWAL OF DEPENDENT AND / OR ADDICTIVE SUBSTANCES
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
CA2329881C (en) * 1998-05-11 2010-03-16 Novo Nordisk A/S Compounds with growth hormone releasing properties
RU2141320C1 (en) * 1998-07-14 1999-11-20 Научно-исследовательский институт фармакологии Томского научного центра РАМН Hemorheological agent
FR2782008B1 (en) * 1998-08-07 2003-04-25 Sod Conseils Rech Applic USE OF GINKGO BILOBA EXTRACTS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF AMYOTROPHIC SIDE SCLEROSIS

Similar Documents

Publication Publication Date Title
SI1353668T1 (en) Processes for the preparation of pharmaceutical preparations containing epothilone analogues for the treatment of cancer
PT1353668E (en) Processes for the preparation of pharmaceutical preparations containing epothilone analogues for the treatment of cancer
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
IL196301A0 (en) Medicament for the treatment of hapatitis c
PL363507A1 (en) Pharmaceutical uses of bisphosphonates
ZA200300434B (en) Medicinal herbal compounds for the prevention and treatment of diabetes.
AU2002366355A1 (en) SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
HU0103558D0 (en) Pharmaceutical composition for the treatment of stroke and traumatic brain insury
EP1406571A4 (en) Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
IL158289A (en) Mercaptoacetylamide derivatives, a process for their preparation and their use as medicaments for the treatment of hypertension and chf
AU2002249111A1 (en) Process for the preparation of a medical implant
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2002312897A1 (en) Drugs for the treatment of the alzheimer disease
AU2002334001A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
AU2002330095A1 (en) Flavonoids for treatment of diabetes
HUP0400928A3 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
ZA200309479B (en) Pharmaceutical formulation having a masked taste and method for the production thereof
GB0127832D0 (en) Method for the preparation of pharmaceutical nanosuspensions
EP1509220A4 (en) A pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4- 2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl -1-oxaspiro 2,5 octan-6-one
HUP0100223A3 (en) Use of ginkgo biloba extracts for preparing a medicine
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
HUP0400925A3 (en) Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases
AU2002246151A1 (en) Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases